PE106299A1 - Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indol - Google Patents
Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indolInfo
- Publication number
- PE106299A1 PE106299A1 PE1998000717A PE00071798A PE106299A1 PE 106299 A1 PE106299 A1 PE 106299A1 PE 1998000717 A PE1998000717 A PE 1998000717A PE 00071798 A PE00071798 A PE 00071798A PE 106299 A1 PE106299 A1 PE 106299A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- disorders
- trifluoromethyl
- chlorine
- fluorine
- Prior art date
Links
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 3
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000000460 chlorine Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 239000011737 fluorine Substances 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 101100495911 Arabidopsis thaliana CHR10 gene Proteins 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 102100020802 D(1A) dopamine receptor Human genes 0.000 abstract 1
- 229940099567 Dopamine D4 receptor agonist Drugs 0.000 abstract 1
- 101000931925 Homo sapiens D(1A) dopamine receptor Proteins 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE a ES 0-1; CUANDO a ES CERO,"X" PUEDE FORMAR UN ENLACE OPCIONAL CON EL CARBONO ADYACENTE A V; V ES CHR10, R10 ES H o ALQUILO C1-C6; T ES N o CH; X ES N o CR11; R11 ES H, ALQUILO C1-C6, ALCOXI C1-C6, OH, CIANO; "Y" Y Z SON N o CR12; R12 ES H, CLORO, FLUORO, TRIFLUOROMETILO, ENTRE OTROS; R1 ES H, FLUORO, CLORO, BROMO, TRIFLUOROMETILO, ENTRE OTROS; R2, R6, R7, R8, R9 SON H, FLUORO, CLORO, BROMO, ENTRE OTROS; R3 Y R4 SON H o ALQUILO C1-C6; R5 ES H, ALCOXI C1-C6, TRIFLUOROMETILO, ENTRE OTROS; CUANDO a ES 1; R1 Y R1O FORMAN JUNTOS UN COMPUESTO DE FORMULA II; b ES 0-1; A Y B SON CH, CH2, O, S, NH o N. CON LA CONDICION QUE CUANDO "X" ES N, EL DOBLE ENLACE ENTRE X Y V NO EXISTE, ENTRE OTRAS CONDICIONES. UN COMPUESTO PREFERIDO ES 2-[4-(3-TRIFLUOROMETIL-FENIL)-PIPERAZIN-1-ILMETIL]-1H-INDOL, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS UNO O MAS AGONISTAS DEL RECEPTOR D1, D2, D3, D5 DE DOPAMINA. EL COMPUESTO I ES UN AGONISTA DEL RECEPTOR D4 DE DOPAMINA POR LO QUE PUEDE SER UTIL PARA TRATAR TRASTORNOS DEL SISTEMA DE LA DOPAMINA COMO TRASTORNOS PSICOTICOS, TRASTORNOS DEL MOVIMIENTO, TRASTORNOS GASTROINTESTINALES, ABUSO DE SUSTANCIAS QUIMICAS, TRASTORNOS VASCULARES Y CARDIOVASCULARES, TRASTORNOS OCULARES Y TRASTORNOS DEL SUENO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5576497P | 1997-08-15 | 1997-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE106299A1 true PE106299A1 (es) | 1999-11-02 |
Family
ID=22000003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000717A PE106299A1 (es) | 1997-08-15 | 1998-08-10 | Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indol |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1003739A2 (es) |
| JP (1) | JP2002536291A (es) |
| KR (1) | KR20010022507A (es) |
| CN (1) | CN1265660A (es) |
| AP (1) | AP9801321A0 (es) |
| AR (1) | AR017019A1 (es) |
| AU (1) | AU8457298A (es) |
| BG (1) | BG104069A (es) |
| BR (1) | BR9811557A (es) |
| CA (1) | CA2297486C (es) |
| CO (1) | CO4960656A1 (es) |
| DZ (1) | DZ2583A1 (es) |
| EA (1) | EA200000023A1 (es) |
| HR (1) | HRP980441A2 (es) |
| HU (1) | HUP0003425A3 (es) |
| ID (1) | ID23803A (es) |
| IL (1) | IL133960A0 (es) |
| IS (1) | IS5336A (es) |
| MA (1) | MA24632A1 (es) |
| NO (1) | NO20000722D0 (es) |
| OA (1) | OA11286A (es) |
| PA (1) | PA8457001A1 (es) |
| PE (1) | PE106299A1 (es) |
| PL (1) | PL338947A1 (es) |
| SK (1) | SK1352000A3 (es) |
| TN (1) | TNSN98151A1 (es) |
| TR (1) | TR200000414T2 (es) |
| UY (1) | UY25144A1 (es) |
| WO (1) | WO1999009025A2 (es) |
| ZA (1) | ZA987304B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU226859B1 (en) * | 1997-10-27 | 2009-12-28 | Neurosearch As | Phenyl- or heteroaryl-homopiperazines, their use and medicaments containing them |
| EP0953567A3 (en) * | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
| HRP20020567A2 (en) | 1999-12-30 | 2005-04-30 | H. Lundbeck A/S | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| GB0017952D0 (en) * | 2000-07-22 | 2000-09-13 | Univ Manchester | Treatment of dyskinesia |
| EP1177792A3 (en) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| AU2002336273A1 (en) | 2001-03-09 | 2002-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Heterocyclic compounds and their use as histamine h4 ligands. |
| PL377087A1 (pl) | 2002-09-06 | 2006-01-23 | Janssen Pharmaceutica, N.V. | Związki heterocykliczne |
| WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
| JP4859665B2 (ja) | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
| US7618980B2 (en) | 2004-07-14 | 2009-11-17 | Bristol-Myers Squibb Company | Pyrrolo(oxo)quinolines as 5HT ligands |
| US7572805B2 (en) | 2004-07-14 | 2009-08-11 | Bristol-Myers Squibb Company | Pyrrolo(oxo)isoquinolines as 5HT ligands |
| JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
| JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| JO2849B1 (en) * | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| ES2400710T3 (es) | 2007-04-23 | 2013-04-11 | Janssen Pharmaceutica, N.V. | Tia(dia)zoles como antagonistas del receptor de dopamina 2 de disociación rápida |
| JP5431305B2 (ja) | 2007-04-23 | 2014-03-05 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 高速解離性ドパミン２受容体アンタゴニストとしての４−アルコキシピリダジン誘導体 |
| ES2398625T3 (es) | 2008-07-03 | 2013-03-20 | Janssen Pharmaceutica N.V. | 6-(1-Piperazinil)-piritazinas sustituidas como antagonistas de receptores 5-HT6 |
| CA2730774C (en) | 2008-07-31 | 2016-09-13 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| EP3686196B1 (en) * | 2017-09-20 | 2024-06-12 | Hangzhou Innogate Pharma Co., Ltd. | Polycyclic compound acting as ido inhibitor and/or ido-hdac dual inhibitor |
| WO2021216665A1 (en) * | 2020-04-22 | 2021-10-28 | Anima Biotech Inc. | Collagen 1 translation inhibitors and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB944443A (es) * | 1959-09-25 | 1900-01-01 | ||
| WO1993001181A1 (en) * | 1991-07-03 | 1993-01-21 | The Upjohn Company | Substituted indoles as anti-aids pharmaceuticals |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| CA2146018A1 (en) * | 1992-10-23 | 1994-05-11 | Paul David Leeson | Dopamine receptor subtype ligands |
| GB9305644D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
| AU6215594A (en) * | 1993-03-18 | 1994-10-11 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
| AU6435594A (en) * | 1993-04-15 | 1994-11-08 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
| DE4414113A1 (de) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
| TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
| ZA968661B (en) * | 1995-11-17 | 1998-04-14 | Upjohn Co | Oxazolidinone antibacterial agent with tricyclic substituents. |
| TW504510B (en) * | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
-
1998
- 1998-08-05 IL IL13396098A patent/IL133960A0/xx unknown
- 1998-08-05 KR KR1020007001093A patent/KR20010022507A/ko not_active Ceased
- 1998-08-05 AU AU84572/98A patent/AU8457298A/en not_active Abandoned
- 1998-08-05 PL PL98338947A patent/PL338947A1/xx unknown
- 1998-08-05 EA EA200000023A patent/EA200000023A1/ru unknown
- 1998-08-05 CN CN98807831A patent/CN1265660A/zh active Pending
- 1998-08-05 EP EP98935229A patent/EP1003739A2/en not_active Withdrawn
- 1998-08-05 AP APAP/P/1998/001321A patent/AP9801321A0/en unknown
- 1998-08-05 TR TR2000/00414T patent/TR200000414T2/xx unknown
- 1998-08-05 BR BR9811557-0A patent/BR9811557A/pt not_active IP Right Cessation
- 1998-08-05 SK SK135-2000A patent/SK1352000A3/sk unknown
- 1998-08-05 CA CA002297486A patent/CA2297486C/en not_active Expired - Fee Related
- 1998-08-05 ID IDW20000197A patent/ID23803A/id unknown
- 1998-08-05 JP JP2000509706A patent/JP2002536291A/ja active Pending
- 1998-08-05 WO PCT/IB1998/001198 patent/WO1999009025A2/en not_active Ceased
- 1998-08-05 HU HU0003425A patent/HUP0003425A3/hu unknown
- 1998-08-10 PA PA19988457001A patent/PA8457001A1/es unknown
- 1998-08-10 PE PE1998000717A patent/PE106299A1/es not_active Application Discontinuation
- 1998-08-12 TN TNTNSN98151A patent/TNSN98151A1/fr unknown
- 1998-08-12 DZ DZ980193A patent/DZ2583A1/xx active
- 1998-08-12 MA MA25210A patent/MA24632A1/fr unknown
- 1998-08-13 AR ARP980104021A patent/AR017019A1/es unknown
- 1998-08-14 ZA ZA9807304A patent/ZA987304B/xx unknown
- 1998-08-14 CO CO98046788A patent/CO4960656A1/es unknown
- 1998-08-14 HR HR60/055,764A patent/HRP980441A2/hr not_active Application Discontinuation
- 1998-08-17 UY UY25144A patent/UY25144A1/es not_active Application Discontinuation
-
2000
- 2000-01-10 BG BG104069A patent/BG104069A/xx unknown
- 2000-01-11 IS IS5336A patent/IS5336A/is unknown
- 2000-02-08 OA OA1200000030A patent/OA11286A/en unknown
- 2000-02-14 NO NO20000722A patent/NO20000722D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PA8457001A1 (es) | 2000-09-29 |
| WO1999009025A3 (en) | 1999-04-15 |
| CN1265660A (zh) | 2000-09-06 |
| CO4960656A1 (es) | 2000-09-25 |
| EA200000023A1 (ru) | 2000-08-28 |
| NO20000722L (no) | 2000-02-14 |
| MA24632A1 (fr) | 1999-04-01 |
| BR9811557A (pt) | 2000-08-22 |
| AU8457298A (en) | 1999-03-08 |
| IS5336A (is) | 2000-01-11 |
| ZA987304B (en) | 2000-02-14 |
| HUP0003425A3 (en) | 2002-02-28 |
| BG104069A (en) | 2001-05-31 |
| WO1999009025A2 (en) | 1999-02-25 |
| UY25144A1 (es) | 2000-12-29 |
| NO20000722D0 (no) | 2000-02-14 |
| DZ2583A1 (fr) | 2003-02-22 |
| KR20010022507A (ko) | 2001-03-15 |
| IL133960A0 (en) | 2001-04-30 |
| HUP0003425A2 (hu) | 2001-10-28 |
| TNSN98151A1 (fr) | 2005-03-15 |
| AP9801321A0 (en) | 2000-02-14 |
| EP1003739A2 (en) | 2000-05-31 |
| CA2297486C (en) | 2005-05-03 |
| AR017019A1 (es) | 2001-08-22 |
| HRP980441A2 (en) | 1999-04-30 |
| ID23803A (id) | 2000-05-11 |
| JP2002536291A (ja) | 2002-10-29 |
| PL338947A1 (en) | 2000-12-04 |
| SK1352000A3 (en) | 2000-08-14 |
| OA11286A (en) | 2003-10-22 |
| TR200000414T2 (tr) | 2000-08-21 |
| CA2297486A1 (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE106299A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indol | |
| PE20010600A1 (es) | Derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina | |
| PE2799A1 (es) | Lactamas e imidas heterociclicas de aralquilo y aralquilideno | |
| PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
| PE16299A1 (es) | Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoreceptores | |
| PE20040720A1 (es) | Derivados de benzodioxol | |
| PE20000947A1 (es) | ACTIVADORES DE hPPARþ Y hPPARO | |
| PE20030610A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano con afinidad a los receptores opioides | |
| PE20030565A1 (es) | Compuestos heterociclicos como agonistas de receptores activados por proliferador de peroxisoma | |
| PE20020637A1 (es) | Derivados de 5-oxo-pirrolidina como agonistas de prostaglandinas | |
| PE20010854A1 (es) | USO DE DERIVADOS DE PIRIMIDINA 4 SUSTITUIDOS COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO mGluR1 | |
| PE68799A1 (es) | Derivados de tetrahidroisoquinolina como moduladores del receptor de d3 de dopamina | |
| ES2148227T3 (es) | Derivados de 1-piperazino-1,2-dihidroindeno. | |
| PE20040672A1 (es) | Derivados de fenil o heteroaril amino alcano | |
| PE69398A1 (es) | Antagonistas de receptor de benzoxazinona dopamina d4 | |
| PE20061328A1 (es) | Derivados de oxadiazol o tiadiazol como inhibidores de la biosintesis de leucotrienos | |
| PE20030707A1 (es) | Agonistas muscarinicos | |
| PE20001234A1 (es) | Compuestos azabiciclicos sustituidos de heteroaril-aminoetil/benzisoxazol como antagonistas serotonergicos 5-ht1 | |
| PE20110208A1 (es) | Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno | |
| PE20020905A1 (es) | Derivados de alcoxicarbonilaminotetrazolil fenilo o acido alcoxicarbonilamino benzoico como antagonistas ip | |
| PE20080540A1 (es) | Compuestos 4-fenil-2-piridinil-metil sustituidos como moduladores de los canales de sodio con apertura por voltaje | |
| PE20001598A1 (es) | Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina | |
| PE20030943A1 (es) | Agonistas del receptor b3-adrenergico | |
| PE20050862A1 (es) | Derivados de indano heterociclicos sustituidos como antagonistas de los receptores de dopamina d2 y serotonina 2a | |
| PE20060734A1 (es) | Derivado de pirrol sustituido como antagonistas del receptor de androgenos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |